✦ LIBER ✦

P176 Cardiac safety guidelines for the adjuvant use of trastuzumab (Herceptin®) in HER2-positive early breast cancer

✍ Scribed by M.S. Ewer; E.A. Perez; J. Baselga; R. Bell; D. Brutsaert; M. Marty; T. Pienkowski; T.M. Suter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN16 COST-EFFECTIVENESS ANALYSIS OF ADJ

✍ TY Chao; SC Chen; KJ Chang; HK Chang; DR Chen; MF Hou; RK Hsieh; WT Huang; LM Ts 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Management and Outcome of HER2-Positive

✍ Carlo Palmieri; Deep Shah; Jonathan Krell; Ondrej Gojis; Katy Hogben; Pippa Ridd 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 432 KB

HER-2 testing on diagnostic core biopsie

✍ Thomas Roe; E. Massey; A. Chaudhry; R. Price; J. Bristol; H. Chan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

PCN41 ECONOMIC EVALUATION OF TRASTUZUMAB

✍ BA Essers; V Tjan Heijnen; JL Severens; A Novák; U Oron; M Pompen; MA Joore 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Dosimetric Analysis of Cardiac Substruct

✍ Chen, J.; Cao, L.; Yang, Z. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

PCN4 BUDGET IMPACT ANALYSIS OF ADJUVANT

✍ E Orlewska; R Aultman; M Krzakowski; T Pienkowski; K Drosik; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB